Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BIRC5 Antibody

Known as: Anti-IAP4 Antibody, Baculoviral IAP Repeat-Containing Protein 5 Antibody, Anti-Survivin Antibody 
Any immunoglobulin that recognizes baculoviral IAP repeat-containing protein 5.
National Institutes of Health

Related topics

Related topics

2 relations
Immune System Processesantigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Piezometric biosensors for anti-apoptotic protein survivin based on buried positive-potential barrier and immobilized monoclonal antibodies.
The anti-apoptotic protein survivin (Sur) plays an important role in the regulation of cell division and inducing the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2013
2013
BIRC5 expression is a poor prognostic marker in Ewing sarcoma.
BACKGROUND BIRC5 (Survivin), an inhibitor of apoptosis protein (IAP), is over-expressed in several human cancers and increased… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
2009
2009
Expression pattern of anti-apoptotic protein survivin in dysplastic nevi.
UNLABELLED The anti-apoptotic protein survivin was detected in a panel of 27 dysplastic nevi. From each representative paraffin… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2009
2009
Anti-survivin antibody responses in lung cancer.
Existing evidence regarding spontaneous anti-survivin humoral responses in lung cancer is inconclusive. Moreover, despite that… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
PURPOSE Survivin (BIRC5) is a promising tumor biomarker. Conflicting data exist on its prognostic effect in breast cancer. These… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Anti-apoptotic factors including IAP-survivin and bcl-2 are involved in carcinogenesis and predict for disease outcome for… Expand
  • figure 1
  • table II
  • table I
  • figure 2
  • figure 3
Is this relevant?
2004
2004
Immunohistochemical analysis of survivin expression in primary breast cancers.
BACKGROUND AND PURPOSE Survivin, an inhibitor of apoptosis, is expressed in fetal tissues but undetectable in normal adult… Expand
Is this relevant?
2002
2002
Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
In the current study, the immunohistochemical localization of survivin was correlated with the histologic diagnosis in healthy… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin.
Apoptosis plays a fundamental part in epidermal homeostasis, and apoptotic cells have been detected in normal and diseased skin… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Neuroblastoma may be aggressive with a dismal outcome or regress spontaneously. Prognostic factors including age, stage, and… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE